Dr. Laura Niedernhofer and Dr. Paul Robbins to speak at Undoing Aging 2019

Mountain View, CA / Berlin, Germany

We are happy to announce Dr. Laura Niedernhofer and Dr. Paul Robbins, University of Minnesota, as speakers for the 2019 Undoing Aging Conference as a speaker for the 2019 Undoing Aging Conference. ​

Laura Niedernhofer, M.D., Ph.D., is the director of the Institute on the Biology of Aging & Metabolism (iBAM) at the University of Minnesota. Internationally recognized as an expert in the molecular and cellular basis of aging, Dr. Niedernhofer’s expertise is in how cellular senescence is regulated as well as the role of DNA repair during aging.

Prior to joining the University of Minnesota, Dr. Niedernhofer was at the Scripps Research Institute in Florida. She has trained at MIT, Duke, Vanderbilt and Erasmus Medical Center in the Netherlands. This year she was awarded a Glenn Award for Aging Research and the Vincent Cristofolo Rising Star Award in Aging Research from the American Federation for Aging Research.​

---

Paul D. Robbins, Ph.D. is the Associate Director of the Medical Discovery Team on Aging and the Institute on the Biology of Aging and Metabolism (iBAM) and Professor of Biochemistry, Molecular Biology and Biophysics at the University of Minnesota Medical School. Before moving to the University of Minnesota, Dr. Robbins was a Professor of Molecular Medicine at The Scripps Research Institute (TSRI) in Jupiter, Florida and Director of the TSRI Center on Aging.  Previously he was a Professor of Microbiology and Molecular Genetics, Director of Basic Research for the Molecular Medicine Institute and Co-Director of the Paul Wellstone Cooperative Muscular Research Center at the University of Pittsburgh School of Medicine as well as Interim Director of Molecular & Cellular Oncology at the University of Pittsburgh Cancer Institute. 

Paul received his B.A. from Haverford College, his Ph.D. from the University of California at Berkeley and worked as a post-doctoral fellow in the laboratory of Dr. Richard Mulligan at the Whitehead Institute for Biomedical Research at MIT.  He has co-authored over 340 peer-reviewed manuscripts and 185 book chapters and reviews with a H-index of 118 and has edited four books. Dr. Robbins’ current research is focused on developing therapeutic approaches, including gene therapy, small molecules and stem cells, to treat age-related diseases.​

​"Paul and Laura have made huge contributions to the biomedical gerontology field in recent years. Their work focuses on the characterisation and alleviation of the aspects of aging that are driven by DNA damage. At UA2019, their talks will describe their recent advances in the mechanistic understanding of DNA damage, aided by spectacularly good mouse models, and also their identification of natural products with potent senolytic activity", says Aubrey de Grey.

---